logo Click here for the Institute for Clinical and Translational Science Home Page Click here for the UC Irvine Home Page
 
 
 
 

Funding

All applications are submitted at www.icts.uci.edu/grants 

View funded projects ›

ICTS Pilot Grant »

ICTS Translational Science Pilot Grants

Purpose: To encourage early exploration of high-risk translational research ideas focused on emerging areas of basic and applied science with clear relevance to clinical application.

Rationale: The ICTS Translational Science Pilot Grant Program is inspired by the Common Fund's NIH Director’s Transformative Research Award initiative (formerly known as the Transformative Research Project (TR01]). The ICTS Translational Science Pilot Grants are designed specifically to support exceptionally innovative and/or unconventional research projects that have the potential to create or overturn fundamental paradigms.

The UCI ICTS is pleased to announce a new call for the Pilot Project Awards Program. Up to six one-year awards in the amount of $25,000-$30,000 will be conferred in this round. The estimated funding period is April 1, 2017 - March 31, 2018.

Eligible Projects

Clinical Translational Science Projects, currently not funded and aimed at obtaining preliminary results for a full application for extramural funds, are considered eligible. Emphasis will be placed on innovation and transformative potential of submitted proposals. The content of proposals, while obviously linked to applicants’ current research, should demonstrate a clear evolution towards novel, relevant, and untested research areas.

A clinical translational science project is defined as any project aimed at accelerating the transition from discoveries arising from laboratory, clinical, or population studies into clinical applications. Note that in addition to traditional research studies, these awards are also open to proposals to pilot innovations in translational workforce development and training, new strategies for accelerating the research process, or new approaches to recruiting participants into clinical trials from challenging populations (e.g., patients in a NICU or underrepresented populations).

Principal Investigators (PIs) must be full time UCI faculty from any school or discipline; junior faculty are especially encouraged to apply, but established investigators pursuing novel research lines are also welcome. Faculty from the Children’s Hospital of Orange County (CHOC) and the Long Beach VA* are also encouraged to apply. If CHOC and VA applicants do not have a joint UCI faculty appointment, their proposals must have a UCI CO-PI.

*All awards to CHOC and VA will occur via a subcontract; no overhead costs will be provided.

 

To apply, please use this link ICTS Pilot Project

 

Letter of Intent

Deadline: Friday, September 9, 2016

A letter of intent is encouraged, but not required.  Please include the project title and names of Principal Investigator and co-Investigators.

 

Proposal

Deadline: Friday, September 30, 2016

All material must include the investigator’s name at the top right corner, and use a font no smaller than 11 pts, with margins no narrower than 0.5 inches.

  • Abstract (1 page)
  • Research Plan (5 pages max, plus references) must include:
    • Specific Aims
    • Significance (be sure to address the translational potential of the project)
    • Innovation
    • Approach
    • Plans for applying for extramural funding
  • Biosketch for PI and Co-I’s (New NIH format)

  • Home department letter of support
  • Budget (itemized, 1 page maximum) 
  • Budget Justification
    • Funds cannot be used to support the PI’s salary, computer purchases, or travel. Other personnel salaries are allowable.
    • No overhead will be provided for outside institutions
  • UCI Financial Disclosure 
  • For junior faculty only (assistant professor or lower): Please name senior faculty sponsor 

For junior faculty (assistant professor or equivalent and lower): before funds are released, a senior faculty mentor from the awardee's home department must agree to act as a mentor (including general project supervision, participation in an initial milestone-setting meeting, and periodic progress report meetings).

Regulatory Approval: Please note that while having regulatory approval (IRB, IACUC) is not necessary at the time of submission, awarded funds will not be released, by NIH mandate, until such approval has been received.  Because NIH does not allow carry-forward on these one-year awards, if all regulatory approvals have not been received 6 months after award date, the ICTS may withdraw the award.

Resubmissions: Applications that were not funded during a prior call for ICTS pilot awards may be resubmitted a second time by checking the appropriate box during the application process. Resubmissions will have the opportunity to address the criticisms raised during the review process; however, no additional space will be allowed for the rebuttal, which will have to be included in the 5-page limit of the research plan. A maximum on ONE resubmission will be allowed for each previously unfunded project.

Milestones and Monitoring: Before funds are released, a meeting between the awardee, the department sponsor, a department financial analyst, and ICTS staff will review specific milestones to gauge project progression. Continuation of support throughout the entire award period will be contingent upon meeting the project's goals in a timely manner.

Review Process: Review criteria will include:

  • Significance and impact of the proposed research
  • Qualifications of the PI and research team
  • Innovation
  • Approach; Scientific strength of the research design
  • Scientific environment
  • Translational nature of the project
  • Project feasibility within the proposed time frame
  • Likelihood of generating extramural funding

For more information, please contact Dr. Margaret Schneider at margaret.schneider@uci.edu or April Bagaporo at abagapor@uci.edu

To apply, please use this link ICTS Pilot Project

APPLICATION DEADLINES:

Letter of Intent (recommended): Friday, September 9, 2016; 5 PM

Full Proposal: Friday, September 30, 2016; 5 PM

Notification Emails for Receipt of Proposal: A notification email indicating the receipt of your proposal will be sent within 24 hours of submission. If you have not received an email, please contact April Bagaporo (714-456-7524).

 

Campus-Community Research Incubator Program »

University of California, Irvine
Institute for Clinical & Translational Sciences
Community Engagement Unit (CEU)
Campus-Community Research Incubator Program

Overview
The Campus-Community Research Incubator Program (CCRI) is a small grant fund mechanism designed to foster collaborative research-oriented projects between university researchers and community organizations. There are two levels of grant funding available: 1. Pilot CCRI $8,000-$10,000 (for research applications) and 2. Mini CCRI $3,000-$5,000 (for capacity and partnership building applications). The estimated funding period is April 1, 2017 - March 31, 2018.

Eligibility
Grants are awarded only to teams comprised of UCI researchers and community organization representatives. Applicants can be:

  • 501c3 Community organizations
  • UCI-based researchers, including faculty, healthcare providers, post-doctoral researchers, graduate students, or senior researchers may apply for CCRI funds

Proposals must demonstrate an active engagement between UCI researchers and community representatives. Specifically, projects must demonstrate they are co-designed and clearly state the anticipated benefits to each partner.

All projects require UCI Human Research Institutional Review Board (IRB) approval or an exemption determination prior to funds being released. It is recommended that the IRB application be submitted prior to final submission of this funding application. In addition to UCI IRB approval, community organizations may have their own IRB processes.

All personnel on proposals must take the Human Subjects Protections and HIPAA tutorial prior to funds being disbursed.
Tutorials:
Human Subject Protection https://www.citiprogram.org/Default.asp 
HIPAA http://apps.research.uci.edu/tutorial/

All applications must be submitted electronically.

Types of Awards
Awards may be used for:

  • Research-based activities: Pilot CCRI $8,000-$10,000 (for research applications)
  • Research activities include but are not limited to data collection, analyses, and/or pilot studies.
  • An example of a pilot CCRI is a study that will generate findings to be further studied or tested in a larger follow-up research study.
  • Fifty-one percent (51%) of research funds are distributed directly to the community partner
  • Capacity- and partnership-building activities: Mini CCRI $3,000-$5,000 (for capacity and partnership building applications)
  • Capacity-building and project planning activities include but are not limited to trainings, data set organization, technology, project development for future research

Use of Funds
Two funding levels are anticipated for this round:
Pilot CCRI $8,000-$10,000 (for research applications)
Mini CCRI $3,000-$5,000 (for capacity and partnership building applications)

Funds may be used to purchase research supplies, support research assistants, or buy out an applicant's time.

At least 51% of award funds must be distributed to the community partner to support their research activities. Community partner funds may also be used to supplement academic partner’s project activities, if necessary.
Funds may not be used to purchase food, but may be used to purchase study participant gift cards.
Funds must be spent and projects completed by March 31, 2018.

Reporting Requirement

  • Awardees are required to complete documentation for a face-to-face activation meeting that takes place at the beginning of the funding, and a report with highlights, findings, and further actions, at the close of the award period, March 31, 2018.
  • Awardees are expected to develop a poster that presents their findings and display the poster at the annual UCI/ICTS Translational Science Day at the UCI Student Center. Additional information will be given in the notice of awards.
  • Awardees are expected to present their projects twice at a CCRI Presentation Breakfast, once at the beginning of the funding period, and again at the end. Additional information will be given in the notice of awards.
  • Awardees are required to acknowledge the ICTS in all publications and presentations.

Award Application Deadline:  Friday, September 30, 2016

Selection Criteria
Awards will be made competitively. In general, proposals that demonstrate the following will be given highest priority:

  • Focus on integrating innovative community-based practices that accelerate discoveries toward better health and healthcare delivery and/or contribute to the understanding clinical translational science and the social determinants of health
  • Have formed or established a partnership (an existing partnership prior to applying for CCRI)
  • Demonstrate project ingenuity/innovation
  • Have a high likelihood of meaningful positive impact (ex. changing clinical care in a positive way, future research possibilities)
  • Have matching funds or in kind donations
  • Those with existing IRB approval

 

The CCRI applications for research activities are rigorously reviewed by UCI faculty and community partners. Each application will have at least one review from an academic and a community member. Please be sure to clearly indicate to which funding mechanism you are applying.

Scoring for Research-based activities (Pilot CCRI) is based on the following:

  • Significance and impact
  • Qualifications of the PI and research team
  • Innovation
  • Approach; Scientific strength of the research design
  • Scientific environment
  • Translational nature of the project
  • Project feasibility within the proposed time frame
  • Likelihood of generating extramural funding
  • Strength/potential of the partnership

Scoring for Capacity- and partnership-building applications (Mini CCRI) is based on the following:

  • Significance and impact
  • Qualifications of the PI and partnership team
  • Innovation
  • Scientific environment
  • Translational nature of the project
  • Project feasibility within the proposed time frame
  • Likelihood of generating extramural funding
  • Strength/potential of the partnership

Application Components

  • Biosketch (NIH new format) of University Partner and biosketch or CV of Community Partner
  • Timeline (1 Page)
    • A detailed plan for completion of the project by March 31, 2018
  • Letter of support from the university partner and the community partner
  • Budget (itemized, 1 page maximum). Must clearly state the following:
    • Total budget for the project
    • Amount requested from the ICTS
    • Breakdown of funds to be directed to the community partner vs. university partner (remember, > 51% of funds are to be sent to the community partner)
  • Budget Justification
    • Funds cannot be used to support the PI’s salary, computer purchases, or travel. Other personnel salaries are allowable.
    • No overhead will be provided for outside institutions
  • Implementati on Plan (click link to download form)
  • UCI Financial Disclosure (For UCI Faculty: Form 800 and if required Form 810; for community members Form 800SR)

If you have questions, please contact

Robynn Zender, MS 
CEU Manager, Community Research 
Institute for Clinical and Translational Science
949-824-3160 E-mail: rzender@uci.edu  

Deadline: Friday, September 30, 2016 at 5pm
To apply, please use this link: HERE.

Special Pilot in Biomedical and Health Informatics »

The ICTS is pleased to announce a special call for a Pilot Project focused on Biomedical and Health Informatics. The ICTS will be offering one, one-year award in the amount of *$20,000 for an innovative, translational informatics project. The funding period is April 1, 2016 – March 31, 2017.

 

Eligible Projects

 

A translational project is defined as any project aimed at accelerating the transition from discoveries arising from laboratory, clinical, or population studies into clinical applications. Potential topics for this special pilot on Biomedical and Health Informatics include, but not limited to:

 

  • Novel ways for secondary use of structured or unstructured healthcare data, such as predictive modeling, data/text mining, and natural language processing
  • Informatics innovations designed to facilitate the conduct of clinical and translational research, such as applications for enhancing standardization and reusability of patient care data, and applications for improving the efficacy of patient screening, recruitment, and engagement and retention
  • Computational medicine and bioinformatics
  • Consumer/personal health informatics and community health informatics
  • Security and privacy and confidentiality protection

 

Principal Investigators (PIs) must be full-time UCI faculty from any school or discipline; junior faculty are especially encouraged to apply, but established investigators pursuing novel research lines are also welcome.

 

* Please note that before funds can be released to an awarded application, all required approved IRB and/or IACUC documents must be in place (as well as all other internal regulatory approvals)and an administrative approval by the NIH (that will be requested directly by the ICTS office) is also required.

 

Application Materials

 

  • Abstract
    • A brief description of the research plan limited to 1 page with font no smaller than 11 points and 0.5 inch margins.
      • Must included Specific Aims of the project
  • Biosketch of PI (NIH or NSF format)
  • Research plan (3–5 pages, plus references)
    Must include explanation of the following:
    • Why the project fits the definition of translational science, or will produce knowledge or applications to facilitate translational science research
    • Detailed plan and timeline for future extramural fund application(s)
  • Budget and Budget Justification (itemized, 1 page maximum)
    Must clearly state the following:
    • Total budget for the project
    • Amount requested from the ICTS
    • Matching amount committed by Home Department (If available)
  • UCI Financial Disclosure (Form 800) http://research.uci.edu/forms/docs/coi/PHS-Disclosure-Form-800.doc
  • Home department letter of support, stating availability of matching funds (if available)

 

* ICTS funds cannot be used to support the PI’s salary, computer purchases, or travel. Other personnel salaries are allowable.

 

Regulatory Approval: Please note that while having regulatory approval (IRB, IACUC) is not necessary at the time of submission, awarded funds will not be released, by NIH mandate, until such approval has been receive.

 

Notification Emails for Receipt of Proposal

 

A notification email indicating the receipt of your protocol will be sent within 24 hours of submission. If you have not received an email, please contact April Bagaporo (abagapor@uci.edu).

 

Milestones and Monitoring

 

Before funds are released, a meeting between the awardee, the department sponsor, a department financial analyst, and ICTS staff will set specific milestones to gauge project progression. Continuation of support throughout the entire award period will be contingent upon meeting the project’s goals in a timely manner.

 

Review Process

 

Review criteria will include:

 

  • Overall project scientific merit
  • Translational nature of the project
  • Scientific environment
  • Project feasibility within the proposed time frame
  • Likelihood of generating extramural funding
  • Intrinsic scientific strength and innovation of the research plan
  • Significance and impact of the proposed research
  • Qualifications of the PI

 

For more information, please contact April Bagaporo at abagapor@uci.edu.

 

To apply, please click on www.icts.uci.edu/grants (A valid UCI NetID will be required).

 

THE APPLICATION DEADLINE

 

Monday, March 14 , 2016; 5:00 p.m. 

Special Olympics Pilot Research »

The UCI ICTS in conjunction with the Exercise Medicine & Sport Science Institute in partnership with the Special Olympics is pleased to announce a call for a Pilot Research Project focused on the Special Olympics Healthy Athletes Program. This funding mechanism is aimed at promoting novel collaborations among at least two distinct UCI Schools and/or disciplines to further the mission of the Special Olympics. The UCI EMSSI will be offering two, 18 month awards in the amount of $25,000.


Special Olympics is a global movement of people creating a new world of inclusion and community, where every single person is accepted and welcomed, regardless of ability or disability. Currently a preschool program has been developed to give the child athletes the opportunity to participate in athletic activities in the school environment. Young AthletesTM is a unique sport and play program developed by Special Olympics for children with intellectual disabilities (ID). The focus is on fun activities that are important to mental and physical growth.


Many children with ID also have physical challenges. Through Young Athletes, kids ages 2 to 7 enjoy games and activities that help them develop fundamental skills such as running, jumping, hopping, skipping, sliding, throwing and hand-eye coordination. As children improve strength and balance, they are more likely to become active and play with their peers, which helps with their cognitive development.

Apply here

Conte Center »

The UCI Conte Center on Brain Programming in Adolescent Vulnerabilities

 

2015-16 Pilot projects grants

 
Under this program, two $30,000 grants will be awarded to innovative and currently unfunded, science projects focusing on the effects of early life experience / environment on brain development and cognitive and / or emotional outcomes.
 
Proposals may involve human subjects or animal models. Projects may employ molecular (including epigenetics and bioinformatics), cellular, systems or in vivo approaches. Molecular- and in vivo imaging, computational / modeling strategies and a combination thereof are welcome. Successful applications will resonate with the objectives of the new NIH NIMH P50 Conte Center, as described in the center’s mission statement: “…to address the complex developmental mechanisms responsible for adolescent vulnerability to emotional and cognitive disorders. These disorders are generally believed to arise from an interaction of genetic and environmental influences during sensitive developmental epochs, yet there are major gaps in our knowledge regarding the nature of the environmental signals, and the mechanisms by which they promote disease”.
 
The optimal proposals will lay the foundation for subsequent applications for extramural funding.
 
APPLICATION PROCEDURES
All UCI full-time Faculty, at the rank of Assistant Professor and above will be eligible to apply.
Applications should be submitted at www.icts.uci.edu  no later than 5:00 pm Thursday, October 1, 2015. The applications should consist of a single word document, typed in font no smaller than 11 and with half-inch margins, including:
 
1)  Project Description (Abstract, no more than 300 words)
2)  A four-page research plan including
a)  Specific Aims;
b)  Significance/Impact;
c)  Approach/Design
3)  Biosketches (NIH in new format) of Applicant(s).
4)  A 1-page itemized budget (no salary support will be allowed)
 
Applications will undergo review by an extramural review committee. Awardees will be announced by December 1, 2015.
 
Awardees will be expected to provide a six-month and a twelve-month report, and present their data to members of the Conte Center.
 
For any additional information please contact Ms. Diana Vigil (dvigil1@uci.edu) for Administration questions, Tallie Z. Baram, MD, PhD (tallie@uci.edu) for questions relating to Science, or Pietro Galassetti, MD PhD, (pgalasse@uci.edu).
Dean’s Triumvirate Grant »


The Dean's Office in the School of Medicine, in conjunction with the UC Irvine Institute for Clinical and Translational Science, is pleased to announce a new call for applications for the Dean's Triumvirate Grants.

This funding mechanism is aimed at promoting novel collaborations among clinical and basic science researchers from the School of Medicine and other UC Irvine schools and programs.

Available funding will include one $50,000 award and possibly one or two $15,000 awards

The overarching goal is to provide opportunities for investigators who have considered interacting with other colleagues in different fields of study, but could not establish the collaboration for logistical, structural or financial reasons.

The general premise is that establishing these new collaborations will enhance integration of basic and clinical science and lead to the submission and eventual funding of truly unique extramural grant applications.

Ultimately, this process is expected to accelerate the translation of novel scientific concepts into tangible clinical applications.

We are not currently accepting applications.

Strategic Planning Translational Collaborative Discovery Grant »


This grant is offered through the Strategic Planning Task Force for Translational Science for the UC Irvine School of Medicine, in collaboration with the UC Irvine Institute for Clinical and Translational Science.

Under this program, one $50,000 grant will be awarded annually to an innovative and currently unfunded translational science project featuring the collaboration of at least two investigators who will be project co-principal investigators. One investigator will be a basic science researcher, the other a clinical investigator. At least one must have a main appointment in the School of Medicine. 

We are not currently accepting applications.

 


For all Training and Scholarship Awards (including KL-2 and T-L1 Awards), please see Education & Training ›

For external funding, please use the UC Irvine-sponsored funding search engine, PIVOT ›

For questions regarding funding opportunities or to stay informed as new funding opportunities are made available, contact April Bagaporo at abagapor@uci.edu

Thank you to all the reviewers who help make these programs a success.

April Abagapo, Administrator
ICTS
Geoffrey Abbott, PhD
Pharmacology
Gregory Adams, PhD
Physiology & Biophysics
Behnoosh Afghani, MD
Pediatric Infectious Diseases
Dritan Agalliu, PhD
Developmental and Cell Bio
Jung Ah-Lee, PhD
Nursing Science
Thomas Ahlering, MD
Urology
Shlomit Aizik, PhD
Pediatrics
Yama Akbari
Neurology
Bogi Andersen, MD
Biological Chemistry
Craig Anderson, PhD
Emergency Medicine
Hoda Anton-Culver, PhD
Epidemiology
Kenneth Baldwin, PhD
Physiology & Biophysics
Tallie Baram, MD, PhD
Anatomy and Neurobiology
Alan Barbour, MD
Microbiology & Molecular Genetics
Lee Bardwell, PhD
Developmental and Cell Bio
Cristobal Barrios, MD
Surgery
Stanley Bassin, Ed.D
Medicine
Lbachir BenMohamed, PhD
Cellular and Molecular Immunology, Opthalmology
Rimal Bera, MD
Psychiatry and Human Behavior
Jill Berg, PhD
Nursing Science
Michael Berman, MD
Obstetrics & Gynecology
Hans Ulrich Bernard, PhD
Molecular Biology and Biochemistry
Michael Berns, PhD
Developmental and Cell Biology
Naveen Bhandarkar, Asst. Clin Prof
Otolaryngology
John Billimek, PhD
Medicine
Matt Blurton-Jones
Andersen Bogi, MD
Biological Chemistry
Charles Boicey, MS RN-BC
Informatics Solution Architect
Daniela Bota, MD, PhD
Medicine
Elliot Botvinick, PhD
Biomedical Engineering
Peter Bowler
Ecology & Evolutionary Biology
Roni Bracha, Administrator
Institute for Clinical and Translational Science
Matthew Brenner, MD
Medicine
Michael Brenner, MD
Medicine
Alyssa Brewer, PhD
Cognitive Science
Donald Brown, PhD
Opthalmology
Tim Bruckner, PhD
Public Health and Planning
Szofia Bullain, Asst. Adjunct
Neurology
William Bunney, MD
Psychiatry and Human Behavior
Claudia Buss, PhD
Pediatrics
Cathy Cahill
Vincent Caiozzo, PhD
Orthopaedic Surgery
Jose Camacho, MD
Pediatrics
David Camerini, PhD
Infectious Disease
Phil Carpenter, MD
Pathology
Robert Carroll, Assoc. Clin Pro
Department of Medicine
Albert Cerussi, PhD
Beckman Laser Institute
Richard ChamberlinGeorge Chandy, PhD
Physiology & Biophysics
Elizabeth Chao, MD
Pediatrics
Susan Charles, PhD
Psychology & Social Behavior
Chuansheng Chen, PhD
Psychology and Social Behavior
Zhongping Chen, PhD
Biomedical Engineering
Robert Chilcote
Pediatrics
Bernard Choi, PhD
Biomedical Engineering
Sarah Choi, PhD
Nursing Science
Melanie Cocco, PhD
Molecular Biology and Biochemistry
Dan Cooper, MD
Pediatrics
Carl Cotman, PhD
Neurology
Josh Cotter
Orthopaedic Surgery
Karina Cramer, PhD
Neurobiology and Behavior
Steven Cramer, MD
Neurology
Brian Cummings, PhD
Physical Medicine and Rehabilitation
Lisa Dahm, PhD
Clinical Informatics
Jessica De Haene
Ralph Delfino, MD, PhD
Epidemiology
Ryan Dellinger, PhD
Medicine
Micheal Demetriou
Neurology
Michelle Digman, PhD
Biomedical Engineering
Philip DiSaia, MD
Obstetrics & Gynecology
Joseph Donnelly, MD
Pediatrics
Peter Donovan, PhD
Biological Chemistry
Anthony Durkin, PhD
Beckman Laser Institute and Medical Clinic
Robert Edwards, MD, PhD
Pathology
Frederick Ehlert, PhD
Pharmacology
Sonja Entringer, PhD
Pediatrics
Lorraine Evangelista, PhD
Nursing Science
Gregory Evans, MD
Surgery
Laura Findeiss, MD
Vascular and Interventional Radiology
Mark Fisher, MD
Neurology
Lisa Flanagan, PhD
Neurology
Angela Fleischman, Assistant Profe
Medicine
Pamela Flodman, MS
Pediatrics
Donald Forthal, MD
Medicine
Michelle Fortier, PhD
Anesthes & Perioperative Care
Clarence Foster, MD
Surgery
David Fruman, PhD
Immunology
Pietro Galassetti, MD, PhD
Pediatrics
Christine Gall, PhD
Anatomy & Neurobiology
Sunil GandhiAnand Ganesan, MD
Dermatology
Jay Gargus
Jean Gehricke, PhD
Pediatrics
Steven George, MD, PhD
Chemical Engineering and Materials Science
Lisa Gibbs, MD
Family Medicine
Wendy Goldberg, PhD
Psychology and Social Behavior
Alan Goldin, MD, PhD
Microbiology & Molecular Genetics
Sidney Golub, PhD
Microbiology & Molecular Genetics
Ian Gordon, MD, PhD
Surgery
Celia Goulding, PhD
Molecular Biology and Biochemistry
Sergei Grando, MD, PhD
Dermatology
Stan Grant, Professor
Civil & Environmental Engineering
Kim Green, PhD
Neurobiology and Behavior
Sheldon Greenfield, MD
Health Policy Research Institute
Josh Grill
Psychiatry & Human Behavior
Alex GuentheFadia Haddad, PhD
Pediatrics
Jered Haun, PhD
Biomedical Engineering
Neal Hermanowicz, MD
Neurology
Guy Hidas, MD
Bang Hoang, MD
Musculoskeletal Oncology
Alison Holman, PhD
Nursing Science
Lan Huang, PhD
Physiology & Biophysics
Taosheng Huang, MD, PhD
Pediatrics
Christopher Hughes, PhD
Molecular Biology and Biochemistry
Robert Hunt
Hirohito Ichii, MD PhD
Surgery
David Imagawa, MD, PhD
Surgery
Matthew Inlay
James Jester, PhD
Opthalmology
Deepa JeyakumarWangcun Jia, PhD
Beckman Laser Institute
Victor Joe, MD
Burn Surgery
Lisa JonesKwang-Mook Jung, PhD
Anatomy & Neurobiology
Zeev Kain, MD
Clinical Operations
Peter Kaiser, PhD
Biological Chemistry
Kamyar Kalantar-Zadeh, MD, MPH, PhD
Medicine
Sherrie Kaplan, PhD, MPH
Healthcare Measurement and Evalutations
Claudia Kawas, MD
Neurology
David Keator, MCS
Brain Imaging Center
Kristen Kelly, MD
Dermatology
Richard Kelly
Anesthesia & Perioperative Care
Cristina Kenney
Joyce Keyak, PhD
Radiological Sciences
Arash Kheradvar, MD, PhD
Biomedical Engineering
Antoine Khoury
Pediatric
Virginia Kimonis, MD
Genetics and Metabolism
Henry Klassen, MD, PhD
Stem Cell and Retinal Regeneration Program
Michael Kleinman, PhD
Medicine
Diane Krause, PhD
Pharmacology
John Krolewski, MD, PhD
Pathology and Laboratory Medicine
Frank Laferla, PhD
Neurobiology and Behavior
Kimberley Lakes, PhD
Pediatrics
Jonathan Lakey, PhD
Surgery
Mark Langdorf, MD
Clinical Emergency Medicine
Vu LeAlana Lebron, Assistant Profe
Health Sciences
Wen-Hwa Lee, PhD
Biological Chemistry
Marc Lerner, MD
Pediatrics
Sharon Leu, PhD
Pediatrics
Jacob Levin, PhD
Physical and Biological Sciences
Gail Lewandowski, PhD
Reeve-Irvine Research Center
Joseph LewisGuann-Pyng G.P. Li, Director
CALIT2
Michael Lilly, MD
Clinical Medicine
Charles LimoliRobert Lingua, Clinical Prof
Ophthalmology
Wendy Liu, PhD
Biomedical Engineering
Leslie Lock, PhD
Biological Chemistry
John Longhurst
Medicine
Shahram Lotfipour, MD, MPH
Emergency Medicine
Ira Lott
Pediatrics
Kim Lu, MD
Pediatrics
Ulrike Luderer, MD, MPH, PhD
Medicine
Hudel Luecke
Molecular Biology & Biochemistry
Zhigang David Luo, MD, PhD
Medicine
Andrej Luptak, PhD
Chemistry
Gary Lynch, PhD
Psychiatry & Human Behavior
David Lyon
Fabio Macciardi, MD, PhD
Psychiatry and Human
Gerald Maguire, MD
Psychiatry and Human Behavior
Shaista malik, MD, MPH, PhD
Medicine
Alberto Maneta, MD
Obstetrics & Gynecology
Bill Mantulin, PhD
Beckman Laser Institute
William Mantulin, PhD
Beckman Laser Institute and Medical Clinic
Craig Martens, PhD
Chemistry
Elspeth McDougall, MD
Urology
Christine McLaren, PhD
Epidemiology
Dan Mercola, MD, PhD
Pathology and Laboratory Medicine
Frank Meyskens, MD
Biological Chemistry and Public Health
Michael Montoya, PhD
Anthropology
Edwin Monuki, MD, PhD
Pathology
Hamid Moradi, MD
Internal Medicine
Edgar Moran, MD
Medicine
Timothy Morgan
Medicine
Tahseen Mozaffar, MBBS
Neurology
Dana Mukamel, PhD
Medicine
Ruth Mulnard, D.N.Sc
Nursing Sciene
Jim Murry
IT & Informatics
Jacqueline Myers
Dwight Nance, PhDEdward Nelson, MD
Hematology/Oncology
J Stuart Nelson, MD, PhD
Surgery, Biomedical Engineering
Zoran Nenadic, D.Sc
Biomedical Engineering
Robert Newcomb, PhD
UCI General Clinical Research Center
Danh Nguyen
Ninh Nguyen, MD
Surgery
Andrei Novac, MD
Psychiatry
Ray Novaco, PhD
Psychology and Social Behavior
Elizern Nussbaum, MD
Clinical Pediatrics
Andrew Odegaard, PhD
Epidemiology
Oladele Ogunseitan, PhD
Health Sciences/Public Health
Ellen Olshansky, PhD
Nursing Science
Gary Olson, PhD
Information and Computer Sciences
Judith Olson, PhD
Information and Computer Sciences
SaiHong Ou, MD, PhD
Health Science
Maryann PackMadeleine Pahl, MD
Medicine
Hannah Park, PhD
Epidemiology
Steve Park, MD, PhD
Infectious Diseases
Pranav Patel, MD
Cardiology
Danielle Perret, Associate
Physical Med & Rehab
Ellena Peterson, PhD
Pathology
Aimee Pierce, MD
Neurology
Daniele Pilomelli
Anatomy & Neurobiology
Maksim Plikus, PhD
Developmental and Cell Biology
Andria Pontello, MBA RD
ICTS
Wayne Poon, PhD
Mind Research Unit
Eric Potma, PhD
Chemistry
Thomas Poulos, PhD
Molecular Biology & Biochemistry
Michael Prislin, MD
Family Medicine
Ibrahim Ramzy, MD
Pathology
Leslie Randall
John Leslie Redpath, PhD
Emeritus, Radiation Oncology
Christopher Reist, MD
Psychiatry and Human Behavior
Connie Rhee
Joseph Rinehart, MD
Anesthesiology
Annie RoRichard Roberson
Richard RobertsonRobert RobertsonElizabeth Rugg, PhD
Dermatology
Hamid Said, PhD, PharmD
Medicine
Maritza Salazar, PhD
School of Business
Curt Sandman, PhD
Psychiatry and Human Behavior
Suzanne Sandmeyer, PhD
Biological Chemistry
Roz Sandri-Goldin, PhD
Microbiology and Molecular Genetics
Rozanne Sandri-Goldin, PhD
Microbiology and Molecular Genetics
Jean Daniel Saphores, PhD
Planning, Policy and Design
Walter Scacchi, PhD
Institute for Software Research
Margaret Schneider, PhD
Planning, Policy and Design
Steven Schreiber, MD
Neurology
Sabrina Schuck, PhD
Pediatrics
Tara Seery, Asst Clinical
Hematology Oncology
Bert Semler, PhD
Medicine
Shalini Shah, Asst. Clinical
Anesthesia & Perioperative Care
Babak Shahbaba, PhD
Statistics
Kelli SharpYongsheng Shi
Microbiology & Molecular Genetics
Hye-Won Shin, PhD
Pediatrics
Roxane Silver, PhD
Psychology and Social Behavior
Moyra Smith, MD, Ph.D. MFA
Pediatrics
Padhraic Smyth, PhD
Donald Bren School of Information and Computer Sciences
Dara Sorkin, phD
Medicine
Dare Sorkin, phD
Medicine
Craig Stark, Professor
Neurology & Behavior
Robin Steinberg-Epstein, MD
Developmental Pediatrics
Hal Stern, PhD
Statistics
Daniel Stokols, PhD
Epidemiology
Min-ying SU, PhD
Physics
Sandor Szabo, MD, PhD
Pathology
Candice Taylor-Lucas
Pediatrics
Andrea Tenner, PhD
Molecular Biology and Biochemistry
Lorena Teran, MPH, PhD
Pediatrics
Leslie Thompson, PhD
Psychiatry and Human Behavior
Julianne Toohey, MD
Obstetrics & Gynecology
Theodorus Van Erp, Asst Prof
Psychiatry & Human Behavior
Thomas Vasich
Reeve-Irvine Research Center
N.D. Vaziri, MD
Medicine, Physiology and Biophysics
Veronica Vieira, DSc
Health Sciences/Public Health
Pathik Wadhwa, MD, PhD
Psychiatry and Human Behavior
Craig Walsh, PhD
Molecular Biology and Biochemistry
Annabel Wang, MD
Neurology
Ping Wang, PhD
Medicine
Marian Waterman, PhD
Microbiology & Molecular Genetics
Greg Weiss, PhD
Chemistry
Lari Wenzel, PhD
Medicine
Katrine Whiteson
Molecular Biology & Biochemistry
Sharon Wigal, PhD
Medicine
Petra Wilder-Smith
Beckman Laser Institute and Medical Clinic
Deborah Wing, MD
Obstetrics & Gynecology
Brian Wong, MD
Biomedical Engineering
Nathan Wong, PhD, MPH
Medicine
Joseph Wu, MD
Psychiatry and Human Behavior
Haiou YangSun Yang
Medicine
Ilona Yim, PhD
Psychology and Social Behavior
Kyoko Yokomori, PhD
Biological Chemistry
Hiroshi Yoshioka, MD, PhD
Radiological Sciences
Frank Zaldivar, PhD
Pediatrics
Magda Zarki
Donald Bren School of Information and Computer Sciences
Jason Zell, DO, MPH
Medicine
Robynn ZenderFan Gang Zeng, PhD
Otolaryngology
Weian Zhao, PhD
Pharmaceutical Sciences
Kai Zheng, PhD
Informatics
Xiaolin Zi, PhD
Urology